By Dr. Corina Ianculovici, DNP, FAAMFM, ABAAM, AGNP

Skin sags during weight loss because fat volume beneath the skin decreases faster than the skin’s stretched collagen-and-elastin framework can remodel around a smaller body. Years of weight gain, sun exposure, hormonal change, inflammation, aging, and metabolic stress can weaken the connective-tissue architecture that gives skin its firmness and recoil.[1,2] People often regain weight after stopping GLP-1 medication because the biology of hunger, food reward, cravings, insulin resistance, and old eating patterns has not been fully addressed.[3] The Mirelle Method® was designed to change that outcome. At Mirelle Institute for Longevity & Regenerative Medicine, we combine Metabolic Code® assessment of five interconnected physiologic systems, clinician-guided GLP micro-dosing to quiet food noise and retrain reward-driven eating, AccuFit® muscle stimulation integrated with resistance training, individualized nutritional and supplement programs, and Density® radiofrequency collagen banking before, during, and after weight loss.[4-9] This matters because weight loss should not simply make a patient smaller. It should restore metabolic health, protect lean muscle, improve body composition, support long-term behavior change, and preserve the quality of the skin. We also favor deliberate, medically supervised fat loss because active lipolysis can mobilize lipophilic compounds stored in adipose tissue and creates significant metabolic remodeling within fat tissue itself.[10,11]

Weight loss changes more than the number on the scale

Most people begin a weight-loss journey focused on one outcome: a lower number. But the mirror often tells a more complicated story.

A patient may lose 20, 40, or 70 pounds and improve her blood sugar, energy, mobility, and confidence—yet suddenly notice looser skin in the face, neck, arms, abdomen, thighs, knees, or buttocks.

This is not because she “lost weight the wrong way.”

It is because the skin is a living organ, not shrink-wrap.

Skin depends on collagen for strength, elastin for recoil, fibroblasts for repair, hydration for resilience, and a healthy extracellular matrix to maintain its architecture. When the body carries additional weight for years, the skin expands to accommodate the volume below it. Over time, collagen fibers can become less organized, elastin can lose recoil, and the skin envelope may not fully contract after fat mass decreases.[1,2]

That is why weight loss can reveal:

• A softer jawline
• Deflation through the cheeks and temples
• Neck crepiness
• Loose upper-arm skin
• Abdominal laxity
• Thigh and knee laxity
• A body that is healthier and smaller, but not yet fully supported structurally

At Mirelle, we believe weight loss must be managed as both a metabolic transformation and a structural transformation.

GLP-1 therapy changes food noise.

The Mirelle Method® teaches patients what to do with that opportunity.

For many patients, the greatest benefit of GLP-1 therapy is not simply eating less. It is the sudden quieting of food noise.

Patients often describe a remarkable shift: fewer intrusive thoughts about food, less reward-driven eating, reduced cravings, earlier satiety, and a greater ability to pause before making food decisions.

This is clinically important because many people do not struggle with food because they “lack discipline.” They struggle because food has become intertwined with stress, reward, fatigue, loneliness, habit, insulin resistance, sleep disruption, and neurobehavioral reinforcement.

Research has shown that GLP medications can reduce hunger, energy intake, cravings, and preference for high-fat foods.[4]

A phase 2 randomized trial also found that relatively low-dose GLP reduced alcohol craving and selected alcohol-consumption outcomes, reinforcing the role of GLP-1 signaling in reward-driven behavior.[5]

At Mirelle, our clinician-guided GLP micro-dose strategy is not presented as a shortcut. It is used as a training window.

When appetite is quieter and reward-driven eating is reduced, patients can finally practice a different way of living:

• Protein-first meals
• More stable blood sugar patterns
• Better portion awareness
• Less dependence on ultra-processed foods
• Recognition of true hunger versus emotional hunger
• Consistent meal timing
• Resistance exercise and muscle preservation
• A new relationship with food that can remain when medication changes

The goal is not to create dependence on medication.

The goal is to create metabolic and behavioral capacity.

Why people regain weight after stopping GLP-1 medication

Weight regain is not a moral failure. It is a predictable biological response when appetite regulation, food reward, insulin resistance, lean-mass loss, stress, and old habits are not addressed at the same time.

In the STEP 1 extension study, participants regained a substantial portion of their lost weight within one year after GLP-1 was discontinued.[3] This is exactly why a prescription-only weight-loss model is incomplete.

A patient may lose weight while medication is reducing hunger, but what happens when life becomes stressful again? What happens when cravings return? What happens when muscle mass has declined? What happens when the patient no longer knows how to eat without the medication doing the work?

The Mirelle Method® is designed around the maintenance question from the beginning.

We do not wait until a patient is ready to stop medication before discussing maintenance. We create the maintenance strategy

while the patient is actively losing.

The Mirelle Method® begins with metabolic restoration - not guesswork

Not everyone gains weight for the same reason. Two individuals may have the same body weight, the same age, and the same frustration, but entirely different metabolic roadblocks.

One may have insulin resistance and food cravings. Another may have menopause-related fat redistribution and disrupted sleep. Another may have thyroid dysfunction, cortisol dysregulation, low muscle mass, gastrointestinal dysfunction, inflammation, medication-related weight gain, poor protein intake, or years of repeated crash dieting.

That is why Mirelle uses the Metabolic Code® framework as part of a structured precision-health evaluation.

The Metabolic Code® organizes metabolic patterns into five interrelated Triads®:[6]

1. Energy Triad®

Adrenal • Thyroid • Pancreas

This triad evaluates the relationship between stress physiology, thyroid signaling, glucose control, insulin resistance, hunger, cravings, fatigue, and energy production.

2. Resiliency Triad®

Gut • Immune • Brain

This triad examines the connection between digestion, inflammation, the microbiome, mood, cognition, stress response, and the neurobehavioral patterns that can drive eating.

3. Endurance Triad®

Cardio • Pulmonary • Neurovascular

This triad focuses on circulation, oxygenation, vascular health, exercise tolerance, and the physiologic systems that determine whether a patient can truly build endurance and resilience.

4. Detoxification Triad®

Liver • Lymph • Kidneys

This triad addresses the body’s core elimination and metabolic-processing systems, particularly important during active fat loss, medication use, inflammation, and environmental exposure.

5. Potency Triad®

Estrogen • Progesterone • Testosterone

This triad recognizes the role of sex hormones in body composition, insulin sensitivity, muscle mass, energy, sleep, appetite regulation, and metabolic aging.

The Metabolic Code® does not replace medical diagnosis or laboratory medicine. It gives Mirelle a systems-based map for identifying where the patient’s biology may be resisting change.

That is why Mirelle does not give every patient the same diet sheet, the same injection, or the same supplement shelf.

Why not everyone needs the same supplements

Supplements should be targeted - not trendy.

A patient with inadequate protein intake, low vitamin D, poor sleep, constipation, insulin resistance, low ferritin, B12 insufficiency, menopause-related muscle loss, or thyroid dysfunction does not need the same support plan as a patient with a different metabolic pattern.

At Mirelle, the supplement strategy is built around the patient’s Metabolic Code® pattern, symptoms, body composition, dietary history, medication profile, and clinically indicated laboratory findings.

For some patients, the priority may be protein support and muscle recovery.

For others, it may be glucose regulation, sleep restoration, gut support, hormone optimization, nutrient repletion, inflammation support, or targeted metabolic cofactors.

The purpose is not to create a complicated supplement routine.

The purpose is to make every recommendation earn its place in the plan.

Muscle preservation is not optional during weight loss

A smaller body is not automatically a healthier body. Lean muscle is one of the body’s most important metabolic tissues. It supports glucose disposal, insulin sensitivity, mobility, posture, bone health, strength, energy expenditure, and long-term independence.

GLP-1–associated weight loss can include loss of lean mass along with fat mass. That is why muscle preservation must be part of every serious medical weight-loss program.[7]

At Mirelle, we emphasize protein intake, body-composition monitoring, resistance exercise, recovery, and muscle engagement.

AccuFit®  is incorporated as a targeted electrical-muscle-stimulation modality to support neuromuscular activation and muscle conditioning in appropriate patients. It is especially valuable for patients who are deconditioned, recovering confidence with movement, struggling to recruit specific muscle groups, or beginning a more structured resistance-training plan.

The real goal is not simply fat loss. It is body recomposition.

Less harmful adiposity. More strength. Better glucose regulation. Better metabolic reserve.

Density®: collagen banking before the deflation becomes dramatic

Weight loss reveals the condition of the skin. That is why we do not wait until the face and body look deflated or the arms and abdomen feel loose before discussing collagen support.

At Mirelle, we call this collagen banking.

Collagen banking means strategically investing in skin quality before, during, and after a significant body-composition change.

Density® is a sequential monopolar-bipolar radiofrequency platform designed to create controlled dermal heating, stimulate fibroblast activity, and support collagen-and-elastin remodeling.

In a 2025 preclinical study using the Density® sequential monopolar-bipolar RF system, treated skin demonstrated increased epidermal thickness, collagen density, elastin-fiber expression, hydration, and elasticity. The sequential monopolar-bipolar approach produced greater collagen and elastin effects than monopolar treatment alone.[8]

Early clinical data are also encouraging. A 2026 case series involving Density® treatments for facial laxity found visible improvement in wrinkles and laxity, high patient satisfaction, and minimal discomfort in patients with Fitzpatrick skin Types III and IV.[9]

This is why Density® belongs in a weight-loss transformation plan.

Before weight loss

Density® can be used proactively when the patient already has crepiness, early laxity, thinning skin, jowling, neck laxity, or early body laxity.

During weight loss

Density® can support the skin while facial and body volume are changing.

After weight loss

Density® can be used as a corrective strategy for mild-to-moderate laxity, texture changes, crepiness, jawline softening, neck laxity, and selected body areas.

The goal is not to promise that no patient will ever develop loose skin. The goal is to make collagen support part of the weight-loss strategy from the beginning.

Why Mirelle does not chase the fastest possible number on the scale

Fast is not always better. During active fat loss, adipose tissue is not simply disappearing. It is metabolically active tissue undergoing significant remodeling.

Adipose tissue can store lipophilic persistent organic pollutants. During weight loss, circulating concentrations of some of these stored compounds may rise as they redistribute from fat tissue into the bloodstream.[10]

Rapid diet-induced weight loss has also been associated with increased crown-like structures in subcutaneous fat tissue—an indicator of active adipose remodeling and macrophage activity—even while some systemic inflammatory markers improve.[11]

This is one reason Mirelle does not use a reckless “lose as much as possible, as fast as possible” philosophy.

We want patients to lose weight intelligently. That means supporting hydration, protein adequacy, bowel regularity, lean-mass preservation, micronutrient status, liver and kidney function, sleep, stress resilience, and gradual behavior change throughout the process.

Weight loss should leave the patient stronger - not depleted.

A prevention-focused approach to metabolic aging

The Mirelle Method®  is fundamentally prevention-focused.

Excess adiposity, insulin resistance, low muscle mass, sleep disruption, hormonal decline, and chronic inflammation all contribute to the metabolic terrain associated with diabetes, cardiovascular disease, reduced mobility, cognitive decline, and several obesity-associated cancers.

GLP-1 medicines are now being actively studied beyond diabetes and weight management, including in reward-based behaviors, cancer biology, and neurodegenerative pathways.[5,12]

At Mirelle, the focus is to correct the modifiable metabolic risks that influence long-term health: insulin resistance, unhealthy visceral adiposity, muscle loss, hormonal imbalance, poor sleep, inflammatory eating patterns, and loss of metabolic flexibility. That is true longevity medicine.

Why the Mirelle Method® is different

Mirelle Institute for Longevity & Regenerative Medicine Mirelle Method® was built for patients who want more than a refill and a scale reading.

They want to understand:

• Why did I gain weight?
• Why is my body resisting weight loss?
• Why do I crave what I crave?
• How do I preserve my muscle?
• How do I avoid looking deflated?
• What happens when the medication changes?
• How do I create a body that is metabolically healthier—not simply lighter?

The Mirelle Method® answers those questions with a comprehensive model:

1. Decode the metabolic pattern with the Metabolic Code® five-Triad framework.
2. Use clinician-guided GLP therapy strategically to reduce food noise and open the window for behavior change.
3. Protect and build muscle with protein, resistance training, body-composition monitoring, and AccuFit® support.
4. Personalize supplements and nutrition based on the patient’s unique metabolic needs.
5. Preserve and restore skin quality through Density® collagen banking before, during, and after weight loss.
6. Build the maintenance plan from day one so the patient is never left asking what happens after the medication.

Because the true goal is not simply less weight. It is more strength. More confidence. More metabolic resilience. More life.

Request your Personalized  Wellness & Beauty Roadmap™ at Mirelle Institute for Longevity & Regenerative Medicine to determine whether the Mirelle Method® Metabolic Reset,  AccuFit®, and Density®  collagen-banking strategy are appropriate for your goals.

This article is for educational purposes and does not replace individualized medical evaluation, diagnosis, or treatment. GLP-1 therapy, supplements, body-composition programs, and energy-based treatments require clinician-guided candidacy assessment and monitoring.

References

1. Light D, Arvanitis GM, Abramson D, Glasberg SB. Effect of weight loss after bariatric surgery on skin and the extracellular matrix. Plastic and Reconstructive Surgery. 2010;125(1):343-351. doi:10.1097/PRS.0b013e3181c2a657.
2. Hany M, Zidan A, Ghozlan NA, et al. Comparison of histological skin changes after massive weight loss in post-bariatric and non-bariatric patients. Obesity Surgery. 2024;34(3):855-865. doi:10.1007/s11695-024-07066-y.
3. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553-1564. doi:10.1111/dom.14725.
4. Blundell J, Finlayson G, Axelsen M, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism. 2017;19(9):1242-1251. doi:10.1111/dom.12932.
5. Hendershot CS, et al. Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial. JAMA Psychiatry. 2025. doi:10.1001/jamapsychiatry.2024.4789.
6. Metabolic Code® Enterprises. Metabolic Code® TRIADS™: systems-based metabotyping framework. Accessed June 2026.
7. Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes, Obesity and Metabolism. 2024;26(S4):16-27. doi:10.1111/dom.15728.
8. Kumar N, Baek SY. Epidermal and dermal regeneration through sequential monopolar and bipolar radiofrequency: evidence from an aging mouse model. Aesthetic Surgery Journal Open Forum. 2025;7. doi:10.1093/asjof/ojaf111.
9. Chottawornsak N, de Almeida GOO, Sungkyu J, et al. Safety and efficacy of a hybrid sequential monopolar/bipolar pulsed radiofrequency device for facial rejuvenation in skin types III and IV: A case series. International Journal of Aesthetic Plastic Surgery. 2026. doi:10.1177/30499240261424061.
10. Malarvannan G, Van Hoorenbeeck K, Deguchtenaere A, et al. Dynamics of persistent organic pollutants in obese adolescents during weight loss. Environment International. 2018;110:80-87. doi:10.1016/j.envint.2017.10.009.
11. Alemán JO, et al. Effects of rapid weight loss on systemic and adipose tissue inflammation and metabolism in obese postmenopausal women. Journal of the Endocrine Society. 2017;1(6):625-637. doi:10.1210/js.2017-00020.
12. Wang L, et al. Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes. JAMA Network Open. 2024;7(7).